Shares in psychedelic drug developer Compass Pathways are sliding today after it announced that it will slash its headcount by 30% and focus all its efforts on its treatment-resistant depression (TRD) ...
Explore MongoDB stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MDB. MongoDB's Next Growth Driver Isn't What Most Investors Expect MongoDB Inc projected high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback